Corporate ActionAug 11, 2026, 08:02 PM
Silexion Therapeutics Prices Public Offering at $0.65/Share
AI Summary
Silexion Therapeutics Corp. announced the pricing of a public offering of 3,846,161 ordinary shares (or equivalents) and series E warrants at a combined price of $0.65 per share. The offering is expected to generate approximately $2.5 million in gross proceeds. The company plans to use the net proceeds to advance its SIL204 clinical trial and for general corporate purposes.
Key Highlights
- Silexion Therapeutics priced a public offering of 3,846,161 ordinary shares/equivalents and series E warrants.
- The combined public offering price is $0.65 per share/equivalent and accompanying warrants.
- Series E warrants have an exercise price of $0.65 per share and expire in five years.
- Gross proceeds from the offering are expected to be approximately $2.5 million.
- Net proceeds will be used to advance the SIL204 clinical trial and for general corporate purposes.
- H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
Price Impact
More from SLXN